NDA (New Drug Application)
ANDA (Generic Application)
Track protection status across key markets to assess launch feasibility.
It is formulated by 1 pharmaceutical company such as RECORDATI RARE. It is marketed under 1 brand name, including SIGNIFOR LAR KIT. Available in 5 different strengths, such as EQ 20MG BASE/VIAL, EQ 40MG BASE/VIAL, EQ 60MG BASE/VIAL and others, and administered through 1 route including FOR SUSPENSION;INTRAMUSCULAR.
API availability: Loading API feasibility...
Licensing: 1 potential partnersUS Launch window: Loading launch window...
Stay ahead with worldwide patent expiry and latest updates.
FDA approval history for this ingredient
Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.
Key expiration dates for US patents covering this ingredient
Stay ahead with worldwide patent expiry insights, market data, and research updates.
Latest drug strengths approved by FDA
| Strength | Route of Administration | Companies | Latest Approval Date |
|---|
Patents approved by the FDA for the ingredient
|
|
Patent Number | Publication Date | Legal Status | Patent Expiry Date | |
|---|---|---|---|---|---|
| {"application_id":"58123","ingredient":"PASIREOTIDE PAMOATE","trade_name":"SIGNIFOR LAR KIT","family_id":"b49d1f80331c4dfd8eba","publication_number":"US7759308B2","cleaned_patent_number":"7759308","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-10-25","publication_date":"2010-07-20","legal_status":"Granted"} | US7759308B2 Formulation | 20 Jul, 2010 | Granted | 25 Oct, 2026 | |
| {"application_id":"58117","ingredient":"PASIREOTIDE PAMOATE","trade_name":"SIGNIFOR LAR KIT","family_id":"9607462940cd4a38a2ac","publication_number":"US7473761B2","cleaned_patent_number":"7473761","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-12-14","publication_date":"2009-01-06","legal_status":"Granted"} | US7473761B2 Molecular Formulation | 06 Jan, 2009 | Granted | 14 Dec, 2026 | |
| {"application_id":"58162","ingredient":"PASIREOTIDE PAMOATE","trade_name":"SIGNIFOR LAR KIT","family_id":"b57344d67e8b421aa252","publication_number":"US9351923B2","cleaned_patent_number":"9351923","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-05-23","publication_date":"2016-05-31","legal_status":"Granted"} | US9351923B2 Formulation | 31 May, 2016 | Granted | 23 May, 2028 |
Latest clinical trials and research studies for this ingredient
| NCT ID | Title | Status | Phase | Conditions | Start Date | Completion Date |
|---|
Manufacturing Locations
Unlock access to all suppliers of Pasireotide Pamoate
Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.